Trial Profile
A trial to assess pre-transplant sorafenib in patients with hepatocellular carcinoma who were scheduled to receive a deceased donor liver transplant
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Aug 2015
Price :
$35
*
At a glance
- Drugs Sorafenib (Primary)
- Indications Liver cancer
- Focus Adverse reactions; Therapeutic Use
- 21 Aug 2015 New trial record